Often, medicinal development has focused on minute compounds, but peptide partners are progressively demonstrating attention. This innovative strategy involves combining short amino acid chains with complementary therapeutic modalities to address challenging illness mechanisms. By utilizing the unique characteristics of peptides – such as substan